Arjun Sengupta

Dr. Arjun Sengupta

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Cell Reports
Verified
Journal Article
Open access
SZSteven Zhao
Steven Zhao
ATAnnMarie Torres
AnnMarie Torres
RHRyan A. Henry
Ryan A. Henry
STSophie Trefely
Sophie Trefely
Martina WallaceMartina Wallace
Martina Wallace
KWKathryn E. Wellen
Kathryn E. Wellen
Mechanisms of metabolic flexibility enable cells to survive under stressful conditions and can thwart therapeutic responses. Acetyl-coenzyme A (CoA) plays central roles in energy production, lipid metabolism, and epigenomic modifications. Here, we show that, upon genetic deletion of Acly, the gene coding for ATP-citrate lyase (ACLY), cells remain viable and proliferate, although at an impaired rate. In the absence of ACLY, cells upregulate ACSS2 and utilize exogenous acetate to provide acetyl-CoA for de novo lipogenesis (DNL) and histone acetylation. A physiological level of acetate is sufficient for cell viability and abundant acetyl-CoA production, although histone acetylation levels remain low in ACLY-deficient cells unless supplemented with high levels of acetate. ACLY-deficient adipocytes accumulate lipid in vivo, exhibit increased acetyl-CoA and malonyl-CoA production from acetate, and display some differences in fatty acid content and synthesis. Together, these data indicate that engagement of acetate metabolism is a crucial, although partial, mechanism of compensation for ACLY deficiency.

1 December 2015 in Cell Metabolism
Verified
Journal Article
Closed access
BABrian J. Altman
Brian J. Altman
AHAnnie L. Hsieh
Annie L. Hsieh
ASArjun Sengupta
Arjun Sengupta
SKSaikumari Y. Krishnanaiah
Saikumari Y. Krishnanaiah
ZSZachary E. Stine
Zachary E. Stine
CDChi V. Dang
Chi V. Dang

30 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DKDongyeop Kim
Dongyeop Kim
ASArjun Sengupta
Arjun Sengupta
TNTagbo H. R. Niepa
Tagbo H. R. Niepa
BLByung-Hoo Lee
Byung-Hoo Lee
AWAalim Weljie
Aalim Weljie
HKHyun Koo
Hyun Koo
Candida albicans is frequently detected with heavy infection of Streptococcus mutans in plaque-biofilms from children affected with early-childhood caries, a prevalent and costly oral disease. The presence of C. albicans enhances S. mutans growth within biofilms, yet the chemical interactions associated with bacterial accumulation remain unclear. Thus, this study was conducted to investigate how microbial products from this cross-kingdom association modulate S. mutans build-up in biofilms. Our data revealed that bacterial-fungal derived conditioned medium (BF-CM) significantly increased the growth of S. mutans and altered biofilm 3D-architecture in a dose-dependent manner, resulting in enlarged and densely packed bacterial cell-clusters (microcolonies). Intriguingly, BF-CM induced S. mutans gtfBC expression (responsible for Gtf exoenzymes production), enhancing Gtf activity essential for microcolony development. Using a recently developed nanoculture system, the data demonstrated simultaneous microcolony growth and gtfB activation in situ by BF-CM. Further metabolites/chromatographic analyses of BF-CM revealed elevated amounts of formate and the presence of Candida-derived farnesol, which is commonly known to exhibit antibacterial activity. Unexpectedly, at the levels detected (25–50 μM), farnesol enhanced S. mutans-biofilm cell growth, microcolony development, and Gtf activity akin to BF-CM bioactivity. Altogether, the data provide new insights on how extracellular microbial products from cross-kingdom interactions stimulate the accumulation of a bacterial pathogen within biofilms.

1 April 2017 in Cell Metabolism
Verified
Journal Article
Closed access
SKSaikumari Y. Krishnaiah
Saikumari Y. Krishnaiah
GWGang Wu
Gang Wu
BABrian J. Altman
Brian J. Altman
JGJacqueline Growe
Jacqueline Growe
SRSeth D. Rhoades
Seth D. Rhoades
AWAalim M. Weljie
Aalim M. Weljie

9 February 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AWAalim M. Weljie
Aalim M. Weljie
PMPeter Meerlo
Peter Meerlo
NGNamni Goel
Namni Goel
ASArjun Sengupta
Arjun Sengupta
MKMatthew S. Kayser
Matthew S. Kayser
ASAmita Sehgal
Amita Sehgal
Sleep is an essential biological process that is thought to have a critical role in metabolic regulation. In humans, reduced sleep duration has been associated with risk for metabolic disorders, including weight gain, diabetes, obesity, and cardiovascular disease. However, our understanding of the molecular mechanisms underlying effects of sleep loss is only in its nascent stages. In this study we used rat and human models to simulate modern-day conditions of restricted sleep and addressed cross-species consequences via comprehensive metabolite profiling. Serum from sleep-restricted rats was analyzed using polar and nonpolar methods in two independent datasets (n = 10 per study, 3,380 measured features, 407 identified). A total of 38 features were changed across independent experiments, with the majority classified as lipids (18 from 28 identified). In a parallel human study, 92 metabolites were identified as potentially significant, with the majority also classified as lipids (32 of 37 identified). Intriguingly, two metabolites, oxalic acid and diacylglycerol 36:3, were robustly and quantitatively reduced in both species following sleep restriction, and recovered to near baseline levels after sleep restriction (P < 0.05, false-discovery rate < 0.2). Elevated phospholipids were also noted after sleep restriction in both species, as well as metabolites associated with an oxidizing environment. In addition, polar metabolites reflective of neurotransmitters, vitamin B3, and gut metabolism were elevated in sleep-restricted humans. These results are consistent with induction of peroxisome proliferator-activated receptors and disruptions of the circadian clock. The findings provide a potential link between known pathologies of reduced sleep duration and metabolic dysfunction, and potential biomarkers for sleep loss.

6 February 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AVAnna Vysochan
Anna Vysochan
ASArjun Sengupta
Arjun Sengupta
AWAalim M. Weljie
Aalim M. Weljie
JAJames C. Alwine
James C. Alwine
YYYongjun Yu
Yongjun Yu
Significance: Viruses rely completely on host cell metabolism to provide the building blocks and energy required for producing progeny virions. Infection by human cytomegalovirus (HCMV) induces significant alterations in glucose metabolism by increasing glucose uptake and glycolysis as well as redirecting glucose carbon to support the synthesis of biomolecules such as lipids. The significance of acetate as a nutrient has been ignored for a long period. Our studies show that glucose carbon can be converted to acetate and used to make cytosolic acetyl-CoA by acetyl-CoA synthetase short-chain family member 2 (ACSS2) for lipid synthesis, which is important for HCMV-induced lipogenesis and the viral growth. The study provides greater understanding of HCMV pathogenesis and suggests strategies to develop antiviral therapies.